Half-Light Dose BF-200 ALA PDT Promising for Severe Actinic Keratosis, Study Finds Medha Baranwal22 Sept 2024 9:15 PM ISTSpain: Within the specialty of dermatology, a new study has shed light on the effectiveness of a novel photodynamic therapy (PDT) approach using...
Permanent Makeup Pigments Increase Risk of Allergic Contact Dermatitis, finds research Jacinthlyn Sylvia20 Sept 2024 9:00 PM ISTPermanent makeup is a cosmetic tattooing technique used for improving facial features and has gained popularity over the years. However, a new finding...
Alopecia Patients on Low-Dose Minoxidil not at Increased Risk of Pericardial Effusion, suggests study Medha Baranwal19 Sept 2024 8:00 PM ISTUSA: A new study found no evidence of an increased prevalence of pericardial effusions in a small group of alopecia patients undergoing low-dose oral...
Cord Blood Levels of IL-31 and CCL17 and cutaneous markers may predict Atopic Dermatitis Risk in Infants: JAMA Medha Baranwal18 Sept 2024 9:15 PM ISTItaly: A recent observational study published in JAMA Dermatology has shed light on the potential for cord blood serum levels of specific cytokines to...
Study Confirms Baricitinib's Effectiveness for Severe Alopecia Areata and Advocates for Early Trichoscopy Medha Baranwal17 Sept 2024 9:45 PM ISTItaly: A recent 24-week study conducted in Italy has yielded promising results regarding the effectiveness and safety of baricitinib for patients with...
Metformin Emerges as a Promising Therapy for CCCA, Addressing Fibrosis and Hair Loss: JAMA Medha Baranwal16 Sept 2024 9:30 PM ISTUSA: Recent findings from a case series study suggest that low-dose oral metformin, commonly used in diabetes management, may offer new hope for...
Baseline Biomarkers,sex and duration of disease May Predict Dupilumab Efficacy in Atopic Dermatitis: Study Dr Riya Dave15 Sept 2024 9:00 PM ISTResearchers have been able to identify whether patients with atopic dermatitis who receive dupilumab treatment will respond effectively to such...
FDA Approves lebrikizumab for treatment of atopic dermatitis Dr. Kamal Kant Kohli14 Sept 2024 8:00 AM ISTThe US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages above 12 years of...
New Study Links High Systemic Immune-Inflammation Index to Atopic Dermatitis Risk in Adults with BMI Less Than 30 Medha Baranwal12 Sept 2024 10:00 PM ISTUSA: A recent cross-sectional study using data from the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2006 reveals a...
Dysfunctional white blood cells linked to heightened melanoma risk, finds Mayo Clinic study Dr. Kamal Kant Kohli12 Sept 2024 5:00 AM ISTAbout 8 to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems....
Psoriasis Increase Neovascular Age-related Macular Degeneration Risk in Diabetic Patients: Study Jacinthlyn Sylvia10 Sept 2024 9:00 PM ISTA recent nationwide population-based study uncovered a significant link between psoriasis and an increased risk of developing neovascular Age-related...
Topical Ivermectin Effective for Mild to Moderate Inflamed Rhinophyma, Study Finds Medha Baranwal9 Sept 2024 8:15 PM ISTItaly: A recent randomized controlled study has highlighted the effectiveness of topical ivermectin in treating inflamed rhinophyma, a severe form of...
